Adalimumab vs Flutemetamol F 18

## Adalimumab vs Flutemetamol F 18: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Flutemetamol F 18**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Flutemetamol F 18 — N/A.

## Chemical Properties

**Type**: Adalimumab — Antibody; Flutemetamol F 18 — Small molecule.